Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$41.50 0.57 (1.39%)
2/9/2010 3:59 PM

Roche Holding Ltd. (ADR) (RHHBY.PK)

CAPS Rating:
*****

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating RHHBY.PK

Add Stock to Watchlist

What the Community Thinks

Total Members

107 Outperforms
5 Underperforms
 

All-Stars

37 Outperforms
1 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Members bullish on RHHBY.PK are also bullish on:

Members bearish on RHHBY.PK are also bearish on:

Ticker Tags

Defensive (1457), Pharmaceuticals (149), Mega Cap (110), Healthcare (711)
Suggest a tag

Roche Holding Ltd. (ADR) At A Glance

Current Price: $41.50
Last Trade Time: 2/9/2010 3:59 PM
Open: $41.15
Previous Close: $40.93
Daily Range: $41.15 - $41.68
52-Week Range: $26.01 - $45.19
Volume: 315,657
Market Cap: $119.58B
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

RHHBY.PK VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Roche Holding Ltd. (ADR) (RHHBY.PK)

Avatar joshbk (62.61) Submitted: 12/22/09 12:06 AM

It might be going a bit far to call them the Google of biotech, but Roche is positioning themselves well to remain an industry leader well into the future. Their success depends more on the future of biotech than on any specific product. Obviously stay away if you think biotech has a bleak future - ...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 14 :   1 2 3 Next »

Recs

1

 (RHHBY.PK)

Avatar joshbk (62.61) Submitted: 12/22/09 12:06 AM : Outperform Start Price: $42.57 RHHBY.PK Score: 1.39

It might be going a bit far to call them the Google of biotech, but Roche is positioning themselves well to remain an industry leader well into the future. Their success depends more on the future of biotech than on any specific product. Obviously stay away if you think biotech has a bleak future - and between current health care reform, a slow FDA, ect - that just may be the case. But on the other hand, it's hard to see biotech succeeding and Roche failing at the same time.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (RHHBY.PK)

Avatar kevinsteeves (81.26) Submitted: 10/02/09 1:21 PM : Outperform Start Price: $39.90 RHHBY.PK Score: -0.14

More in the pipeline than anyone else right now

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RHHBY.PK)

Avatar svannuffel (80.15) Submitted: 9/04/09 7:33 AM : Outperform Start Price: $38.53 RHHBY.PK Score: 0.89

Leader for H1N1 anti-Flu vaccine... Their other pts are also promising.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RHHBY.PK)

Avatar Hopper39 (60.50) Submitted: 5/06/09 12:36 AM : Outperform Start Price: $31.95 RHHBY.PK Score: 11.72

Should get a nice bump from FDA accelerated approval of Avastin's use on patients with glioblastoma brain cancer. Short-term play.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RHHBY.PK)

Avatar yaacovm (33.26) Submitted: 4/30/09 1:38 PM : Outperform Start Price: $31.50 RHHBY.PK Score: 7.95

TAMYflu

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 14 :   1 2 3 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackEdwardOwens 98.91 02/27/09 Outperform 1Y $28.07+47.84%+47.42%+0.42 Toggle the visibility of 60-Second Pitch and replies

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 281ms